Coya Therapeutics to Present NfL Biomarker Stratification Methodology at 2026 Annual NEALS Meeting

Article summary

Coya Therapeutics announced a poster presentation at the 2026 Annual NEALS Meeting detailing its methodology for using Neurofilament Light Chain (NfL) biomarkers in the ALSTARS clinical trial.